BIVI: BioVie Inc Stock

by  •  • Comments Off on BIVI: BioVie Inc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 286.55
Enterprise Value ($M) 254.06
Book Value ($M) 26.07
Book Value / Share 0.75
Price / Book 10.99
NCAV ($M) 24.87
NCAV / Share 0.71
Price / NCAV 11.52

Profitability (mra)
Return on Invested Capital (ROIC) -1.05
Return on Assets (ROA) -1.29
Return on Equity (ROE) -2.57

Liquidity (mrq)
Quick Ratio 5.90
Current Ratio 5.90

Balance Sheet (mrq) ($M)
Current Assets 45.99
Assets 47.19
Liabilities 21.12
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-10 13D/A Acuitas Group Holdings, LLC 72.07 0.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-02-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)
2022-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)
2022-09-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED JUNE 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SEC
2022-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-03-23 249,385 1,087,815 22.93
2023-03-22 106,403 401,103 26.53
2023-03-21 197,625 568,709 34.75
2023-03-20 162,628 611,874 26.58

(click for more detail)

Similar Companies
BHSEU – Bull Horn Holdings Corp. Unit BIIB – Biogen Inc
BIOR – Biora Therapeutics Inc BLCM – Bellicum Pharmaceuticals Inc
BLPH – Bellerophon Therapeutics Inc


Financial data and stock pages provided by
Fintel.io